Properties (55)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
nan
|
gptkbp:advertising |
focus on high-value generics
|
gptkbp:awards |
various industry awards
|
gptkbp:businessModel |
generic_and_specialty_pharmaceuticals
|
gptkbp:CEO |
gptkb:Glenn_Saldanha
|
gptkbp:clinicalTrials |
ongoing
innovative therapies in-house and outsourced |
gptkbp:collaborations |
various partnerships.
|
gptkbp:community_engagement |
healthcare_initiatives
|
gptkbp:customerBase |
hospitals and pharmacies
|
gptkbp:employees |
over 10,000
|
gptkbp:financialPerformance |
consistent growth
|
gptkbp:founded |
1977
|
gptkbp:founder |
gptkb:Glenn_Saldanha
|
gptkbp:future_plans |
expansion in emerging markets
|
gptkbp:global_presence |
over 80 countries
|
gptkbp:headquarters |
gptkb:Mumbai
gptkb:Mumbai,_India |
https://www.w3.org/2000/01/rdf-schema#label |
Glenmark Generics Ltd.
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:investmentFocus |
transparent communication
R&D investments |
gptkbp:market |
global
approximately $3 billion |
gptkbp:notableEvent |
high standards
|
gptkbp:partnerships |
academic institutions
various global pharmaceutical companies |
gptkbp:patentCitation |
numerous
|
gptkbp:productionLocation |
multiple locations
|
gptkbp:productLine |
diverse portfolio
|
gptkbp:products |
generic drugs
|
gptkbp:regulatoryCompliance |
FDA,_EMA
|
gptkbp:research_areas |
diabetes
neurology oncology dermatology infectious diseases ophthalmology urology gastroenterology cardiovascular respiratory |
gptkbp:researchAndDevelopment |
focus on chronic diseases
|
gptkbp:revenue |
over $1 billion
|
gptkbp:services |
contract manufacturing
|
gptkbp:social_responsibility |
health and education programs
|
gptkbp:stockExchange |
gptkb:BSE
GLENMARK |
gptkbp:subsidiary |
gptkb:Glenmark_Pharmaceuticals_Inc.
|
gptkbp:supplyChain |
efficient and reliable
|
gptkbp:sustainability_initiatives |
environmental responsibility
|
gptkbp:team |
experienced professionals
|
gptkbp:website |
www.glenmarkpharma.com
|